Asia Pacific In-Vitro Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 – Regional Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)

No. of Pages: 121    |    Report Code: TIPRE00022120    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific In-Vitro Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific In-Vitro Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific In-Vitro Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising incidence of chronic diseases
  • 5.1.2 Demand for early diagnostic tools
5.2 Market Opportunities
  • 5.2.1 Growth in point-of-care diagnostic testing
  • 5.2.2 Expansion into emerging healthcare markets
5.3 Future Trends
  • 5.3.1 Adoption of molecular diagnostics
  • 5.3.2 Advancements in lab automation
5.4 Impact of Drivers and Restraints

6. Asia Pacific In-Vitro Diagnostics Market Regional Analysis

6.1 Asia Pacific In-Vitro Diagnostics Market Overview
6.2 Asia Pacific In-Vitro Diagnostics Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific In-Vitro Diagnostics Market Forecast Analysis

7. Asia Pacific In-Vitro Diagnostics Market Analysis – by Product & Services

7.1 Reagents & Kits
  • 7.1.1 Overview
  • 7.1.2 Reagents & Kits: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
  • 7.2.1 Overview
  • 7.2.2 Instruments: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Software & Services
  • 7.3.1 Overview
  • 7.3.2 Software & Services: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific In-Vitro Diagnostics Market Analysis – by Technology

8.1 Immunoassay/Immunochemistry
  • 8.1.1 Overview
  • 8.1.2 Immunoassay/Immunochemistry: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Clinical Chemistry
  • 8.2.1 Overview
  • 8.2.2 Clinical Chemistry: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Molecular Diagnostics
  • 8.3.1 Overview
  • 8.3.2 Molecular Diagnostics: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Microbiology
  • 8.4.1 Overview
  • 8.4.2 Microbiology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Blood Glucose Self-Monitoring
  • 8.5.1 Overview
  • 8.5.2 Blood Glucose Self-Monitoring: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Coagulation & Hemostasis
  • 8.6.1 Overview
  • 8.6.2 Coagulation & Hemostasis: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Hematology
  • 8.7.1 Overview
  • 8.7.2 Hematology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Urinalysis
  • 8.8.1 Overview
  • 8.8.2 Urinalysis: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific In-Vitro Diagnostics Market Analysis – by Application

9.1 Infectious Diseases
  • 9.1.1 Overview
  • 9.1.2 Urinalysis: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Diabetes
  • 9.2.1 Overview
  • 9.2.2 Urinalysis: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Oncology
  • 9.3.1 Overview
  • 9.3.2 Urinalysis: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiology
  • 9.4.1 Overview
  • 9.4.2 Urinalysis: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Autoimmune Diseases
  • 9.5.1 Overview
  • 9.5.2 Urinalysis: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Nephrology
  • 9.6.1 Overview
  • 9.6.2 Urinalysis: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific In-Vitro Diagnostics Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific In-Vitro Diagnostics Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Product & Services
    • 10.1.1.1.2 China: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Technology
    • 10.1.1.1.3 China: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Application
  • 10.1.1.2 India: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Product & Services
    • 10.1.1.2.2 India: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Technology
    • 10.1.1.2.3 India: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Application
  • 10.1.1.3 Japan: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Product & Services
    • 10.1.1.3.2 Japan: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Technology
    • 10.1.1.3.3 Japan: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Application
  • 10.1.1.4 Australia: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Product & Services
    • 10.1.1.4.2 Australia: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Technology
    • 10.1.1.4.3 Australia: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Application
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific In-Vitro Diagnostics Market Breakdown, by Product & Services
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific In-Vitro Diagnostics Market Breakdown, by Technology
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific In-Vitro Diagnostics Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific In-Vitro Diagnostics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Becton Dickinson and Co
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 bioMerieux SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Bio-Rad Laboratories Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Danaher Corp
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 F. Hoffmann-La Roche Ltd
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Qiagen NV
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Siemens AG
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Thermo Fisher Scientific Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - A Market

  1. Abbott Laboratories 
  2. Becton Dickinson and Co
  3. bioMerieux SA 
  4. Bio-Rad Laboratories Inc
  5. Danaher Corp 
  6. F. Hoffmann-La Roche Ltd 
  7. Qiagen NV 
  8. Siemens AG 
  9. Thermo Fisher Scientific Inc
asia-pacific-in-vitro-diagnostics-market